Remove 2026 Remove Appointment Remove Clinic Remove IT
article thumbnail

Geriatric Medicine Board Meeting Summary | Spring 2025

ABIM

The questionnaire gathers information about clinical work and practice patterns, and ABIM uses the information to help update exam blueprints, develop policies for initial certification and MOC, and ensure adequately diverse representation of the profession in research. Community Practice in ABIM Governance* Erica N.

article thumbnail

Infectious Disease Board Meeting Summary | Spring 2025

ABIM

Some members of the Specialty Board were interested in the LKA experience, participant survey results—particularly responses about fairness—and how LKA performance data might reflect on clinical outcomes. ABIM’s website features expansive sections on research related to assessment and clinical outcomes.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Nephrology Board Meeting Summary | Spring 2025

ABIM

The questionnaire gathers information about clinical work and practice patterns, and ABIM uses the information to inform operations, such as updating exam blueprints, developing policies for initial certification and MOC, and ensuring adequately diverse representation of the profession in research and governance.

article thumbnail

GeriPal Takeover! Nancy Lundeberg and Annie Medina-Walpole

GeriPal

I will always, as always, say, you know, you’re welcome to do this in 2026. Annie 02:31 So if you go to the A G S meeting every year, you know that this group of three individuals comprises the AGS literature update. So this is something. This is the plenary to attend. It is a sold out crowd. Of course. We will step aside. Go Cubs, go.

IT 64
article thumbnail

“TAP Dancing” Towards Faster Device Commercialization: CDRH’s Total Product Life Cycle Advisory (“TAP”) Program

FDA Law Blog

Also, it is unclear which office within CDRH appoints the TAP Advisor, e.g., center-level, OPEQ-level, or division-level. Also, it is unclear which office within CDRH appoints the TAP Advisor, e.g., center-level, OPEQ-level, or division-level. It remains to be seen how FDA would define and actually implement the role of a TAP Advisor.